Changes in Metabolic Status in Patients With Total Thyroidectomy (Thyroid cancer)

T

Tel Aviv Sourasky Medical Center

Status

Unknown

Conditions

Thyroid Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01781767
TASMC-12-NV-376-CTIL

Details and patient eligibility

About

This study objective is to evaluate the change in mitochondrial uncoupling protein 2 (UCP2) mRNA expression as function of thyroid activity (TSH, T3 and Free T4).

Full description

Blood will be drown before thyroidectomy, 2 weeks after the operation and 3-4 month after the operation.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients who were diagnosed with thyroid carcinoma and are going to have total thyroidectomy.
  • Patients with unbalanced thyroid hormones.
  • Aged 18-65 years at the time of screening.
  • Provision of written informed consent.

Exclusion criteria

  • Patients with Diabetes.
  • Patients with any other chronic inflammatory diseases.
  • Steroid treatment.

Trial contacts and locations

1

Loading...

Central trial contact

Nachum Vaisman, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems